EMA Authorised: Pemetrexed Pfizer (previously Pemetrexed Hospira) (pemetrexed disodium;pemetrexed disodium hemipentahydrate) — Pfizer Europe MA EEIG

View source ↗

Summary

The European Medicines Agency authorised a pemetrexed disodium product marketed as Pemetrexed Pfizer (formerly Pemetrexed Hospira) for non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed Pfizer (pemetrexed disodium)

Snippet

Status: Authorised. Therapeutic area: Carcinoma, Non-Small-Cell Lung;Mesothelioma. MAH: Pfizer Europe MA EEIG. Decision date: 15/01/2026